In conversation with... Carlos Fernández de Larrea and Damian Green

Listen to The Lancet Oncology

Contenu fourni par The Lancet and The Lancet Oncology. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par The Lancet and The Lancet Oncology ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

1+ y ago 33:50

MP3•Maison d'episode

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2024 13:11 (26d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.

203 episodes

#Cancer #Tumour #Chemotherapy #Radiotherapy #Surgery #Research #Trial #Study #Drug #Metastatic #Palliative #Health and Well-Being #Oncology #Science #Medicine #Podcasting Education #Lancet #Lancet Oncology